Paper Details
- Home
- Paper Details
Once daily baclofen sustained release or gastro-retentive system are acceptable alternatives to thrice daily baclofen immediate release at same daily dosage in patients.
Author: BhattacharyaAmal K, BhowmikShravanti S, JoshiNishith H, KulkarniRahul V, LakhaniJ D, SampatNitin G, SaseNathaniel, VoraPragnesh B
Original Abstract of the Article :
Baclofen, a GABA-agonist, is currently available as an immediate release (IR) formulation for relieving neurogenic spasticity in a variety of disorders. Baclofen IR requires to be administered three times a day which inadvertently increases the chances of medication noncompliance among patients and ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.4103/0028-3886.53284
データ提供:米国国立医学図書館(NLM)
Baclofen: Finding the Right Dose and Delivery
The field of [neurology] is always seeking to optimize treatment for [neurogenic spasticity]. This study explores the use of different [baclofen] formulations for managing spasticity. Researchers compared [once daily baclofen sustained release, gastro-retentive system, and thrice daily baclofen immediate release] in patients with spasticity. They found that [once daily baclofen sustained release and gastro-retentive system] were acceptable alternatives to thrice daily immediate release baclofen at the same daily dose. The study highlighted [the potential for improved patient adherence and reduced side effects] with these alternative formulations.
Improving Baclofen Therapy for Spasticity
This research provides a practical approach to [optimizing baclofen therapy] for patients with spasticity. The study's findings demonstrate [the effectiveness of sustained release and gastro-retentive baclofen formulations] in achieving therapeutic outcomes.
Navigating the Desert of Spasticity Treatment
Managing spasticity can feel like navigating a desert with limited resources. This study offers a beacon of hope for patients, providing [practical alternatives to traditional baclofen therapy] that could enhance their treatment experience.
Dr. Camel's Conclusion
This study offers a refreshing perspective on baclofen therapy for spasticity. The researchers have discovered a new oasis for patients, providing alternative formulations that could improve adherence and minimize side effects.
Date :
- Date Completed 2009-10-29
- Date Revised 2014-07-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.